Aptorum Group Ltd (APM)
5.40
-0.12
(-2.17%)
USD |
NASDAQ |
May 07, 09:47
Aptorum Group Price to Book Value: 1.189 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 1.216 |
| May 03, 2024 | 1.229 |
| May 02, 2024 | 1.191 |
| May 01, 2024 | 1.211 |
| April 30, 2024 | 1.156 |
| April 29, 2024 | 1.075 |
| April 26, 2024 | 1.163 |
| April 25, 2024 | 1.207 |
| April 24, 2024 | 1.224 |
| April 23, 2024 | 1.211 |
| April 22, 2024 | 1.246 |
| April 19, 2024 | 1.266 |
| April 18, 2024 | 1.182 |
| April 17, 2024 | 1.596 |
| April 16, 2024 | 1.684 |
| April 15, 2024 | 1.729 |
| April 12, 2024 | 1.808 |
| April 11, 2024 | 1.896 |
| April 10, 2024 | 1.964 |
| April 09, 2024 | 1.905 |
| April 08, 2024 | 1.878 |
| April 05, 2024 | 1.668 |
| April 04, 2024 | 2.158 |
| April 03, 2024 | 2.200 |
| April 02, 2024 | 2.090 |
| Date | Value |
|---|---|
| April 01, 2024 | 2.019 |
| March 28, 2024 | 1.979 |
| March 27, 2024 | 1.814 |
| March 26, 2024 | 1.846 |
| March 25, 2024 | 1.620 |
| March 22, 2024 | 1.616 |
| March 21, 2024 | 1.685 |
| March 20, 2024 | 1.773 |
| March 19, 2024 | 2.008 |
| March 18, 2024 | 1.635 |
| March 15, 2024 | 1.481 |
| March 14, 2024 | 1.412 |
| March 13, 2024 | 0.903 |
| March 12, 2024 | 1.084 |
| March 11, 2024 | 1.320 |
| March 08, 2024 | 1.435 |
| March 07, 2024 | 1.458 |
| March 06, 2024 | 1.979 |
| March 05, 2024 | 0.3024 |
| March 04, 2024 | 0.3212 |
| March 01, 2024 | 0.3348 |
| February 29, 2024 | 0.3438 |
| February 28, 2024 | 0.3472 |
| February 27, 2024 | 0.342 |
| February 26, 2024 | 0.369 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2899
Minimum
Feb 08 2024
28.51
Maximum
Jul 02 2019
5.468
Average
2.393
Median
Price to Book Value Benchmarks
| TC BioPharm (Holdings) PLC | 1.149 |
| Renalytix PLC | 12.81 |
| Immuron Ltd | 1.221 |
| Adaptimmune Therapeutics PLC | 6.996 |
| Biodexa Pharmaceuticals Plc | 0.7947 |
Price to Book Value Related Metrics
| PS Ratio | 20.35 |
| PEG Ratio | -0.0029 |
| Price | 5.40 |
| Earnings Yield | -11.48% |
| Market Cap | 29.54M |
| PEGY Ratio | -0.0029 |